Genotoxic mechanism of tamoxifen in developing endometrial cancer

Drug Metabolism Reviews
Sung Yeon KimShinya Shibutani

Abstract

Increased risk of developing endometrial cancers has been observed in women treated with tamoxifen (TAM), a widely used drug for breast cancer therapy and chemoprevention. The carcinogenic effect may be due to genotoxic DNA damage induced by TAM. In fact, TAM-DNA adducts were detected in the endometrium of women treated with this drug. TAM is alpha-hydroxylated by cytochrome P450 3A4 followed by O-sulfonation by hydroxysteroid sulfotransferase, and reacts with guanine residues in DNA, resulting in the formation of alpha-(N2-deoxyguanosinyl)tamoxifen adducts. During this metabolic process, short-lived carbocations are produced at the ethyl moiety of TAM as reactive intermediates. TAM-DNA adducts promote primarily G -->T transversions in mammalian cells. The same mutations have been frequently detected at codon 12 of the K-ras gene in the endometrial tissue of women treated with this drug. TAM-DNA adducts, if not readily repaired, may act as initiators, leading to development of endometrial cancers. The reactivity of TAM metabolites with DNA is inhibited in toremifene, where the hydrogen atom has been replaced by a chlorine atom at the ethyl moiety. Therefore, toremifene may be a safer alternative to TAM. This article describes a...Continue Reading

References

Feb 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C K OsborneM W DeGregorio
Jun 22, 1990·Journal of Steroid Biochemistry·L Kangas
Feb 1, 1967·Journal of Reproduction and Fertility·M J Harper, A L Walpole
Jan 1, 1982·Breast Cancer Research and Treatment·V C Jordan
Jan 1, 1984·Pharmacology & Therapeutics·B J Furr, V C Jordan
Feb 19, 1994·Lancet·F E van LeeuwenF W Diepenhorst
Jan 1, 1994·Breast Cancer Research and Treatment·Y P DraganH C Pitot
Feb 1, 1997·Chemical Research in Toxicology·L Dasaradhi, S Shibutani
Mar 1, 1997·Carcinogenesis·M R OsborneD H Phillips
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A U Buzdar, G N Hortobagyi
Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V Stearns, E P Gelmann
May 5, 1998·Chemical Research in Toxicology·I R HardcastleD H Phillips
Oct 28, 1998·Journal of the National Cancer Institute·R M O'ReganV C Jordan
Nov 26, 1998·The New England Journal of Medicine·C K Osborne
Jul 20, 1999·Chemical Research in Toxicology·S ShibutaniM L Pearl

❮ Previous
Next ❯

Citations

Apr 22, 2010·Biochemistry·Chad D MooreGarold S Yost
Jun 20, 2006·Chemical Research in Toxicology·Sung Yeon KimShinya Shibutani
Sep 19, 2006·Chemical Research in Toxicology·Tamara S DowersJudy L Bolton
Mar 22, 2014·BMC Complementary and Alternative Medicine·Nik Soriani Yaacob, Nur Faezah Ismail
May 9, 2012·Cancer Letters·Ketan GajjarFrancis L Martin
May 24, 2011·The Journal of Steroid Biochemistry and Molecular Biology·Marian Y Williams-BrownSalama A Salama
Jan 10, 2008·International Journal of Cancer. Journal International Du Cancer·Yoshinori OkamotoShinya Shibutani
Jan 15, 2010·International Journal of Cancer. Journal International Du Cancer·Y R Santosh LaxmiShinya Shibutani
Sep 9, 2010·International Journal of Cancer. Journal International Du Cancer·Naomi SuzukiShinya Shibutani
Nov 16, 2004·Mechanisms of Ageing and Development·Ibtissam EchchgaddaBandana Chatterjee
Nov 22, 2005·Gynecologic Oncology·Giancarlo GarutiMassimo Luerti
Sep 9, 2005·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·G C RieckS Williams
Mar 12, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Nik Soriani YaacobMohd Nor Norazmi
Jan 5, 2012·Analytical Biochemistry·Vidusha Cyril, Mark T Muller
Jun 17, 2010·The Journal of Rheumatology·Yu ZhangElena Peeva
Oct 9, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Helén AnderssonEva Brittebo
Apr 23, 2019·Expert Review of Clinical Pharmacology·A B Sanchez-SpitmanH J Guchelaar
Apr 13, 2019·Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society·Yoshinori Okamoto, Shinya Shibutani
May 7, 2011·Human Cell·Akira YasueYasuhiro Udagawa
Mar 10, 2005·Mutagenesis·Laura J SchildMiriam C Poirier
Aug 16, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sung Yeon KimShinya Shibutani
Nov 22, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sung Yeon KimShinya Shibutani
Jun 15, 2007·Toxicological Sciences : an Official Journal of the Society of Toxicology·Junya MatsumotoHiroshi Yokota
Sep 12, 2020·ChemMedChem·Lucia Wang, Abhishek Sharma

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.